DNB Asset Management AS reduced its holdings in Davita Inc (NYSE:DVA) by 90.6% during the third quarter, Holdings Channel reports. The institutional investor owned 19,510 shares of the company’s stock after selling 189,100 shares during the quarter. DNB Asset Management AS’s holdings in Davita were worth $1,398,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of the company. Vigilant Capital Management LLC boosted its position in shares of Davita by 250.0% during the second quarter. Vigilant Capital Management LLC now owns 2,100 shares of the company’s stock valued at $146,000 after purchasing an additional 1,500 shares in the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. bought a new stake in shares of Davita during the second quarter valued at approximately $206,000. Green Square Capital LLC bought a new stake in shares of Davita during the second quarter valued at approximately $208,000. IFG Advisory LLC bought a new stake in shares of Davita during the second quarter valued at approximately $213,000. Finally, Atria Investments LLC bought a new stake in shares of Davita during the second quarter valued at approximately $243,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.
Several equities research analysts recently weighed in on DVA shares. Zacks Investment Research upgraded Davita from a “hold” rating to a “buy” rating and set a $81.00 price target on the stock in a research report on Monday, October 8th. JPMorgan Chase & Co. upgraded Davita from an “underweight” rating to a “neutral” rating in a research note on Thursday, September 13th. Finally, ValuEngine upgraded Davita from a “hold” rating to a “buy” rating in a research note on Tuesday, October 9th. Five investment analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. Davita has a consensus rating of “Buy” and an average price target of $82.50.
Davita (NYSE:DVA) last announced its quarterly earnings data on Wednesday, August 1st. The company reported $1.05 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.97 by $0.08. The business had revenue of $2.89 billion during the quarter, compared to analysts’ expectations of $2.88 billion. Davita had a return on equity of 14.49% and a net margin of 4.30%. The firm’s quarterly revenue was up 6.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.92 earnings per share. As a group, research analysts anticipate that Davita Inc will post 4 EPS for the current year.
Davita Company Profile
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.